Wednesday, January 04, 2006


HCV - How to Live with Hepatitis - Hepatitis Foundation International


How to Live with Hepatitis - Hepatitis Foundation International
Research is now being planned and conducted to improve the treatment of chronic hepatitis C (HCV) and hepatitis B (HBV) infections by immunotherapy, and development

Hepatitis C
Interferon alfa-2b, recombinant) for Injection is indicated for the treatment of chronic hepatitis C in patients 18 years of age or older with compensated liver disease who have a history of blood or

Most Chronic Hepatitis C Sufferers Will Develop Cirrhosis in Later
Most Chronic Hepatitis C Sufferers Will Develop Cirrhosis in Later Life Study Suggests Cirrhosis and Liver Disease Nearly Inevitable for People with Hep C Bethesda, Maryland (Sept. 1, 2005) Nearly 80

Hepatitis Research Foundation-Home
Research Foundation plans to raise funds to support research into the treatment of chronic hepatitis C (HCV) and hepatitis B (HBV) infections by immunotherapy and development of a vaccine for HCV. Home

Maxim Pharmaceuticals: Therapeutic Info: Chronic Liver Disease
MA-M0405) designed to evaluate the combination of Ceplene and IFN- in the treatment of chronic hepatitis C patients not previously received treatment with IFN- . The primary purpose of this study